BR9808772A - Composição de vacina multivalente com carreadora misturada - Google Patents

Composição de vacina multivalente com carreadora misturada

Info

Publication number
BR9808772A
BR9808772A BR9808772-0A BR9808772A BR9808772A BR 9808772 A BR9808772 A BR 9808772A BR 9808772 A BR9808772 A BR 9808772A BR 9808772 A BR9808772 A BR 9808772A
Authority
BR
Brazil
Prior art keywords
composition
multivalent vaccine
mixed carrier
conjugates
carrier protein
Prior art date
Application number
BR9808772-0A
Other languages
English (en)
Inventor
Odile Leroy
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9507086&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9808772(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of BR9808772A publication Critical patent/BR9808772A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Abstract

<B>COMPOSIçãO DE VACINA MULTIVALENTE COM CARREADORA MISTURADA<D> A invenção refere-se a uma composição farmacêutica para tratar ou impedir um certo número de infecções provocadas por agentes patogênicos tais como bactérias, compreendendo, como agente imunogênico, um ou diversos polissacarídeos obtidos a partir de um ou de diversos agentes patogênicos. Os polissacarídeos estão sob a forma de conjugados, acoplados a uma proteína carreadora. A composição contém, pelo menos, dois tipos de conjugados, sendo cada um deles caracterizado por, pelo menos, uma proteína carreadora diferente.
BR9808772-0A 1997-05-14 1998-05-14 Composição de vacina multivalente com carreadora misturada BR9808772A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706210A FR2763244B1 (fr) 1997-05-14 1997-05-14 Composition vaccinale multivalente a porteur mixte
PCT/FR1998/000966 WO1998051339A1 (fr) 1997-05-14 1998-05-14 Composition vaccinale multivalente a porteur mixte

Publications (1)

Publication Number Publication Date
BR9808772A true BR9808772A (pt) 2000-09-05

Family

ID=9507086

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9808772-0A BR9808772A (pt) 1997-05-14 1998-05-14 Composição de vacina multivalente com carreadora misturada

Country Status (20)

Country Link
US (2) US7862823B1 (pt)
EP (1) EP0983087B1 (pt)
JP (1) JP2001525815A (pt)
KR (1) KR100709628B1 (pt)
CN (1) CN1154509C (pt)
AT (1) ATE279942T1 (pt)
AU (1) AU748716B2 (pt)
BR (1) BR9808772A (pt)
CA (1) CA2289009C (pt)
CZ (1) CZ295272B6 (pt)
DE (1) DE69827127T2 (pt)
ES (1) ES2227840T3 (pt)
FR (1) FR2763244B1 (pt)
HU (1) HUP0002322A3 (pt)
IL (3) IL132669A0 (pt)
NO (1) NO320415B1 (pt)
NZ (1) NZ500738A (pt)
PL (1) PL189653B1 (pt)
PT (1) PT983087E (pt)
WO (1) WO1998051339A1 (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034792A1 (en) * 1999-03-11 2000-09-13 Pasteur Merieux Serums Et Vaccins Intranasal delivery of pneumococcal polysaccharide vaccines
SI1162999T1 (sl) * 1999-03-19 2007-04-30 Glaxosmithkline Biolog Sa Vakcina proti Streptococcus pneumoniae
GB9909077D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions
FR2806304B1 (fr) * 2000-03-17 2002-05-10 Aventis Pasteur Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0130215D0 (en) * 2001-12-18 2002-02-06 Glaxosmithkline Biolog Sa Vaccine
FR2850106B1 (fr) 2003-01-17 2005-02-25 Aventis Pasteur Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
PL1740217T3 (pl) 2004-04-30 2012-03-30 Novartis Ag Szczepienie koniugatem meningokokowym
GB0409745D0 (en) 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
GB0419846D0 (en) * 2004-09-07 2004-10-13 Chiron Srl Vaccine adjuvants for saccharides
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
EP2425851A1 (en) 2005-04-08 2012-03-07 Wyeth LLC Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
SI1896065T2 (sl) 2005-06-27 2014-12-31 Glaxosmithkline Biologicals S.A. Postopek za pripravo cepiv
JP5135220B2 (ja) 2005-09-01 2013-02-06 ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー 血清群ｃ髄膜炎菌を含む複数ワクチン接種
ES2707499T3 (es) 2005-12-22 2019-04-03 Glaxosmithkline Biologicals Sa Vacuna de conjugado de polisacárido neumocócico
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
CN103933564A (zh) 2007-05-02 2014-07-23 葛兰素史密丝克莱恩生物有限公司 疫苗
EP2170391B1 (en) * 2007-06-20 2017-01-18 Pfizer Ireland Pharmaceuticals Modified polysaccharides for conjugate vaccines
RS54349B1 (en) 2007-06-26 2016-02-29 Glaxosmithkline Biologicals S.A. VACCINE CONTAINING STREPTOCOCCUS PNEUMONIAE Capsular POLYSACCHARIDE CONJUGATES
EP2547357A1 (en) 2010-03-18 2013-01-23 Novartis AG Adjuvanted vaccines for serogroup b meningococcus
BR112013005049A2 (pt) 2010-09-02 2016-05-31 Sanofi Pasteur estabilizador para a preparação de uma composição vacina da pólio seca injetável
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
TR201900778T4 (tr) * 2012-01-30 2019-02-21 Serum Institute Of India Private Ltd İmmünojenik bileşim.
CN104582718B (zh) 2012-10-03 2017-10-24 诺华股份有限公司 免疫原性组合物
WO2016012385A1 (en) 2014-07-21 2016-01-28 Sanofi Pasteur Vaccine composition comprising ipv and cyclodextrins
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
CN105695497B (zh) * 2014-11-27 2019-09-24 中国人民解放军军事医学科学院生物工程研究所 一种细菌多糖修饰的重组融合蛋白的制备方法及其应用
EP3313436B1 (en) 2015-06-23 2020-12-23 Biological E Limited Multivalent pneumococcal conjugate vaccine
CN109862908B (zh) * 2016-08-05 2023-05-02 圣诺菲·帕斯图尔公司 多价肺炎球菌多糖-蛋白质缀合物组合物
MX2019001341A (es) * 2016-08-05 2019-07-04 Sanofi Pasteur Inc Composicion de conjugado de polisacarido neumococico multivalente-proteina.
KR102608081B1 (ko) * 2016-09-30 2023-11-29 바이오로지칼 이 리미티드 폴리사카라이드-단백질 접합체를 포함하는 다가 폐렴구균 백신 조성물
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
BR112019026192B1 (pt) 2017-06-10 2022-05-10 Inventprise, Llc Vacinas de conjugado multivalente com polissacarídeos de conjugado bivalente ou multivalente que fornecem imunogenicidade e avidez melhoradas
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
US11123417B2 (en) * 2018-02-05 2021-09-21 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
CN111757754A (zh) * 2018-02-05 2020-10-09 赛诺菲巴斯德有限公司 多价肺炎球菌多糖-蛋白质缀合物组合物
CA3096358A1 (en) 2018-04-18 2019-10-24 Sk Bioscience Co., Ltd. Streptococcus pneumoniae capsular polysaccharide and immunogenic conjugate thereof
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
WO2020009993A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Improvements in immunogenic conjugates
WO2023200704A1 (en) 2022-04-11 2023-10-19 Sanofi Pasteur Inc. Protein-saccharide conjugation with sodium cyanoborohydride

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5639022A (en) * 1979-09-05 1981-04-14 Hayashibara Biochem Lab Inc Preparation of vaccine
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
SI1162999T1 (sl) 1999-03-19 2007-04-30 Glaxosmithkline Biolog Sa Vakcina proti Streptococcus pneumoniae
GB0130215D0 (en) 2001-12-18 2002-02-06 Glaxosmithkline Biolog Sa Vaccine

Also Published As

Publication number Publication date
AU748716B2 (en) 2002-06-13
NO320415B1 (no) 2005-12-05
NO995349L (no) 1999-11-02
EP0983087B1 (fr) 2004-10-20
ES2227840T3 (es) 2005-04-01
EP0983087A1 (fr) 2000-03-08
PL189653B1 (pl) 2005-09-30
DE69827127D1 (de) 2004-11-25
KR20010012477A (ko) 2001-02-15
IL132669A0 (en) 2001-03-19
CN1255861A (zh) 2000-06-07
ATE279942T1 (de) 2004-11-15
US20110117123A1 (en) 2011-05-19
FR2763244B1 (fr) 2003-08-01
HUP0002322A2 (hu) 2000-11-28
US7862823B1 (en) 2011-01-04
DE69827127T2 (de) 2005-03-24
PL336704A1 (en) 2000-07-03
JP2001525815A (ja) 2001-12-11
HUP0002322A3 (en) 2001-12-28
IL183296A0 (en) 2007-09-20
FR2763244A1 (fr) 1998-11-20
CA2289009A1 (fr) 1998-11-19
PT983087E (pt) 2005-01-31
NZ500738A (en) 2002-03-28
CZ295272B6 (cs) 2005-06-15
KR100709628B1 (ko) 2007-04-19
US8029798B2 (en) 2011-10-04
NO995349D0 (no) 1999-11-02
CZ9904021A3 (en) 2001-06-13
CN1154509C (zh) 2004-06-23
IL132669A (en) 2010-11-30
CA2289009C (fr) 2011-04-26
AU7773098A (en) 1998-12-08
WO1998051339A1 (fr) 1998-11-19

Similar Documents

Publication Publication Date Title
BR9808772A (pt) Composição de vacina multivalente com carreadora misturada
CY1109437T1 (el) ΣΥΝΘΕΣΕΙΣ β-ΓΛΥΚΑΝΩΝ ΚΑΙ ΕΙΔΙΚΩΝ ΑΝΟΣΟΣΦΑΙΡΙΝΩΝ
BRPI0515520A (pt) composição imunogênica, vacina, métodos de preparar uma vacina e de prevenir ou tratar infecção estafilocócica, e, uso de composição imunogênica
EA200000594A1 (ru) Новые макролиды
BR0111222A (pt) Derivados fosfonados de glicopeptìdeo
BRPI0010612B8 (pt) vacinas
BR9710768A (pt) Composto composi-Æo e processos para tratamento de infec-{es bacterianas em um mamifero hospedeiro com necessidade de tal tratamento e para prepara-Æo de 6-0-metileritromicina forma i
BR0210941A (pt) Terapia de combinação de oxazolidinonas substituìdas
BR0210616A (pt) Indóis, benzofuranos e benzotiofenos substituìdos com triamida, composição farmacêutica, uso dos referidos compostos, bem como processo para preparação dos mesmos
BRPI0007487B8 (pt) difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
BR0013010B1 (pt) Formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
TW200633719A (en) Glycoconjugate vaccines containing peptidoglycan
BRPI0516363A (pt) composição para cuidado dos cabelos e processo para preparação de uma composição
BR0313160A (pt) Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto
BR0014767A (pt) Fibras de sementes de plantas e uso
BRPI0519135A2 (pt) macrolÍdeos
BR0106649A (pt) Composição fertilizante contendo enxofre e processo para preparação da mesma
AR031975A1 (es) Compuestos analogos de (1r,cis)-4-(6-amino-9h-purin-9-il) -2-ciclopenteno-1-metanol, proceso para su preparacion, su uso en el tratamiento de infecciones virales, y envase que los contiene
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
BR0009663A (pt) Composições de vacinas antibacterianas
BR0110844A (pt) Composição e processo para tratar plantas
EA200100700A1 (ru) Гены и белки и их применение
BRPI0410967A (pt) compostos, composições e seus usos para o tratamento de infecções por vìrus da famìlia flaviviridae
BR0007966A (pt) Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana
BR0108096A (pt) Método para manter ou melhorar a sìntese de mucinas

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: AVENTIS PASTEUR (FR)

Free format text: ALTERADO DE: PASTEUR MERIEUX SERUMS ET VACCINS S.A.

B25G Requested change of headquarter approved

Owner name: AVENTIS PASTEUR (FR)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020070077844/RJ DE 12/06/2007.

B25D Requested change of name of applicant approved

Owner name: SANOFI PASTEUR (FR)

Free format text: ALTERADO DE: AVENTIS PASTEUR

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 37, INDEFIRO O PRESENTE PEDIDO, TENDO POR BASE O ART. 13 COMBINADO COM O ART. 8O DA LPI 9279/96

B12B Appeal against refusal [chapter 12.2 patent gazette]